Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Guselkumab regulatory update

December 1, 2016 3:12 AM UTC

Johnson & Johnson submitted an MAA to EMA for guselkumab to treat moderate to severe plaque psoriasis in adults. The submission includes data from the Phase III VOYAGE 1, VOYAGE 2 and NAVIGATE trials and the Phase II X-PLORE trial. In November, Janssen submitted a BLA to FDA for the indication (see BioCentury, Nov. 28)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Johnson & Johnson

MorphoSys AG